Artículos de revistas sobre el tema "Bureau of Hospital Reimbursement"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Bureau of Hospital Reimbursement".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
McFarland, Daniel Curtis, Katherine Ornstein y Randall F. Holcombe. "Hospital size and demographics associated with HCAHPS and implications for hospital value-based purchasing (HVBP)." Journal of Clinical Oncology 32, n.º 30_suppl (20 de octubre de 2014): 38. http://dx.doi.org/10.1200/jco.2014.32.30_suppl.38.
Texto completoPalomäki, A., J. Paltta, L. Pirilä, H. K. Heikkilä, P. Isomäki, J. Huhtakangas, T. Sokka-Isler, O. Kaipiainen-Seppänen y K. Eklund. "AB1251 VALIDITY OF RHEUMATOID ARTHRITIS DIAGNOSES IN FINNISH BIOBANK PATIENTS". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 1917.1–1917. http://dx.doi.org/10.1136/annrheumdis-2020-eular.3890.
Texto completoXu, Junfang, Xin Wang, Hongying Hao, Jian Wang y Stephen Nicholas. "Impact of hierarchical hospital reform on patients with diabetes in China: a retrospective observational analysis". BMJ Open 11, n.º 4 (abril de 2021): e041731. http://dx.doi.org/10.1136/bmjopen-2020-041731.
Texto completoDeitelzweig, Steven, Stephen Thompson, Jay Lin, Donna McMorrow y Barbara Johnson. "Impact of CMS VTE Hospital Acquired Conditions (HAC) Policy on Hospital Cost and Revenue Associated with Major Surgical Hip and Knee Procedures." Blood 116, n.º 21 (19 de noviembre de 2010): 3824. http://dx.doi.org/10.1182/blood.v116.21.3824.3824.
Texto completoÁlvarez Roman, Teresa, Elena Monzón Manzano, Ihosvany Fernandez-Bello, Mónica Martín, María Isabel Rivas Pollmar, Raul Justo Sanz, Sara García Barcenilla et al. "Real Life Experience in Clinical Practice with Recombinant Coagulation FVIII-Fc Fusion Protein". Blood 134, Supplement_1 (13 de noviembre de 2019): 4929. http://dx.doi.org/10.1182/blood-2019-127878.
Texto completoPalomäki, A., T. Laitinen, J. Koskela, A. Palotie y N. Mars. "OP0007 MUC5B PROMOTER VARIANT AND LONG-TERM INCIDENCE OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS: A POPULATION BIOBANK STUDY OF 250,000 INDIVIDUALS". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de mayo de 2021): 4.2–4. http://dx.doi.org/10.1136/annrheumdis-2021-eular.619.
Texto completoKoschmieder, Steffen, Susanne Isfort, Dominik Wolf, Florian H. Heidel, Philippe Schafhausen, Martin Griesshammer, Denise Wolleschak et al. "Ruxolitinib Shows Efficacy in Patients with Newly-Diagnosed Polycythemia Vera: Futility Analysis of the Randomized Ruxo-BEAT Clinical Trial of the German Study Group for Myeloproliferative Neoplasms". Blood 134, Supplement_1 (13 de noviembre de 2019): 2944. http://dx.doi.org/10.1182/blood-2019-123985.
Texto completoDunavin, Neil, Lih-Wen Mau, Christa Lea Meyer, Clint Divine, Al-Ola Abdallah, Susan Leppke, Anita D'Souza et al. "Health Care Reimbursement and Service Utilization Among Medicare Beneficiaries with Multiple Myeloma Receiving Autologous Hematopoietic Cell Transplantation in Inpatient and Outpatient Settings". Blood 132, Supplement 1 (29 de noviembre de 2018): 832. http://dx.doi.org/10.1182/blood-2018-99-118423.
Texto completoMeunier, Godelieve, Loïc Ysebaert, Phi Linh Nguyen-Thi, Stephane Lepretre, Anne Quinquenel, Jehan Dupuis, Richard Lemal et al. "First Line Chronic Lymphocytic Leukemia Immunochemotherapy for the Elderly Patients over 79 Years Is Feasible, and Achieves Good Results: A Filo Retrospective Study". Blood 126, n.º 23 (3 de diciembre de 2015): 4170. http://dx.doi.org/10.1182/blood.v126.23.4170.4170.
Texto completoMonzón Manzano, Elena, Ihosvany Fernandez-Bello, Raul Justo Sanz, Larissa Valor, Francisco Javier López-Longo, Angel Robles, Teresa Álvarez Roman, Miguel A. Canales, Victor Jimenez-Yuste y Nora Butta. "Prothrombotic State, Platelet Activation and Netosis in Systemic Lupus Erythematosus". Blood 134, Supplement_1 (13 de noviembre de 2019): 1141. http://dx.doi.org/10.1182/blood-2019-127991.
Texto completoSchlenk, Richard F., Stefan Schönsteiner, Katharina Krempel, Anja Neumann, Walter Fiedler, Peter Brossart, Bernd Hertenstein et al. "Cost-Effectiveness Analysis of Arsenic Trioxide in Combination with All-Trans Retinoic Acid in Acute Promyelocytic Leukemia with Pretreatment White Blood Counts <10G/L". Blood 124, n.º 21 (6 de diciembre de 2014): 2636. http://dx.doi.org/10.1182/blood.v124.21.2636.2636.
Texto completoMcGuirk, Joseph P., Clint Divine, Seung Hyun Moon, Aastha Chandak, Zhiji Zhang y Genovefa A. Papanicolaou. "Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation". Blood 136, Supplement 1 (5 de noviembre de 2020): 42–43. http://dx.doi.org/10.1182/blood-2020-133799.
Texto completoKaufman, Brystana, Diane Holland, Catherine Vanderboom, Cory Ingram, Alice Chun, Erica Langan, Henry Baer-Benson y Joan Griffin. "EVALUATING IMPLEMENTATION COSTS FOR A TRANSITIONAL PALLIATIVE CARE INTERVENTION TO SUPPORT RURAL CAREGIVERS". Innovation in Aging 6, Supplement_1 (1 de noviembre de 2022): 213. http://dx.doi.org/10.1093/geroni/igac059.850.
Texto completoLai, Sheng Jie, T. Wangteeraprasert, T. Sermkaew, O. Nararak, S. Binsard, M. Phanawadee, I. Ieowongjaroen et al. "Evaluation of Three Main Tuberculosis Case Reporting Systems in Satun Province, Thailand, 2011". Outbreak, Surveillance, Investigation & Response (OSIR) Journal 7, n.º 3 (29 de septiembre de 2014): 16–23. http://dx.doi.org/10.59096/osir.v7i3.263288.
Texto completoByrne, Jenny, Joanne Ewing, Adam J. Mead, Heather Oakervee, Gavin Campbell, Ian Amott, Andrew Goringe et al. "Sequence of Second Generation Tyrosine Kinase Inhibitors (TKIs) in the Treatment of Patients with Chronic Phase Philadelphia Chromosome-Positive Chronic Myeloid Leukaemia - Real World Experience in the UK". Blood 134, Supplement_1 (13 de noviembre de 2019): 3434. http://dx.doi.org/10.1182/blood-2019-122893.
Texto completoMcBride, Ali y Daniel O. Persky. "Impact of Treatment Sequencing on Outcomes and Costs in Relapsed Follicular or Other Low Grade B-Cell Non-Hodgkin Lymphoma - Results of an Evidence-Based Budget Impact Model". Blood 136, Supplement 1 (5 de noviembre de 2020): 14–15. http://dx.doi.org/10.1182/blood-2020-141748.
Texto completoXie, Jing, Alan Yong, Catherine Waweru, Thuy Anh Sorof, Ravi K. Goyal, Keith L. Davis, George Follows y Peter Hillmen. "Real-World Treatment Patterns and Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib in the UK: A Preliminary Analysis". Blood 134, Supplement_1 (13 de noviembre de 2019): 5885. http://dx.doi.org/10.1182/blood-2019-123025.
Texto completoShi, Jianwei, Rui Liu, Hua Jiang, Chunxu Wang, Yue Xiao, Nana Liu, Zhaoxin Wang y Leiyu Shi. "Moving towards a better path? A mixed-method examination of China’s reforms to remedy medical corruption from pharmaceutical firms". BMJ Open 8, n.º 2 (febrero de 2018): e018513. http://dx.doi.org/10.1136/bmjopen-2017-018513.
Texto completoSharman, Jeff P., John M. Burke, Habte A. Yimer, Michael A. Boxer, Sunil Babu, Jia Li, Yong Mun y Alexey Danilov. "Final Results from the Multicenter, Open-Label, Phase II GIBB Study of Obinutuzumab+Bendamustine in Previously Untreated Patients with Chronic Lymphocytic Leukemia". Blood 134, Supplement_1 (13 de noviembre de 2019): 4317. http://dx.doi.org/10.1182/blood-2019-122482.
Texto completoAbe, M. A. "Hospital Reimbursement Schemes". Medical Care 23, n.º 9 (septiembre de 1985): 1055–66. http://dx.doi.org/10.1097/00005650-198509000-00004.
Texto completoFoulon, Stephanie, Pascale Cony-Makhoul, Agnes Guerci-Bresler, Marc Delord, Eric Solary, Alain Monnereau, Julia Bonastre y Pascale Tubert Bitter. "Using Healthcare Claims Data to Analyze the Prevalence of Chronic Myeloid Leukemia in France: A Nationwide Population-Based Study". Blood 132, Supplement 1 (29 de noviembre de 2018): 3015. http://dx.doi.org/10.1182/blood-2018-99-111489.
Texto completoWelton, John M. y Kathy Harris. "Hospital Billing and Reimbursement". JONA: The Journal of Nursing Administration 37, n.º 4 (abril de 2007): 164–66. http://dx.doi.org/10.1097/01.nna.0000266846.77178.23.
Texto completo&NA;. "Changes in Hospital Reimbursement". Obstetric Anesthesia Digest 10, n.º 3 (octubre de 1990): 123. http://dx.doi.org/10.1097/00132582-199010000-00002.
Texto completoBegum, J. y M. Nisar. "POS1200-HPR IL-17 OR TNF INHIBITORS - REAL WORLD IMPACT OF SHARED DECISION MAKING IN A NURSE LED BIOLOGICS SERVICE". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de mayo de 2023): 932.2–933. http://dx.doi.org/10.1136/annrheumdis-2023-eular.920.
Texto completoChanan-Khan, Asher, Paula Cramer, Fatih Demirkan, Graeme Fraser, Rodrigo Santucci Silva, Halyna Pylypenko, Sebastian Grosicki et al. "Insights into the Management of Adverse Events in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Experience from the Phase 3 HELIOS Study of Ibrutinib Combined with Bendamustine/Rituximab". Blood 126, n.º 23 (3 de diciembre de 2015): 2936. http://dx.doi.org/10.1182/blood.v126.23.2936.2936.
Texto completoCramer, Paula, Asher Chanan-Khan, Graeme Fraser, Fatih Demirkan, Rodrigo Santucci Silva, Halyna Pylypenko, Sebastian Grosicki et al. "Improvement of Quality of Response with Ibrutinib Plus Bendamustine/Rituximab Vs Placebo Plus Bendamustine/Rituximab for Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)". Blood 126, n.º 23 (3 de diciembre de 2015): 2938. http://dx.doi.org/10.1182/blood.v126.23.2938.2938.
Texto completoBunker, J. P. y R. W. Schaffarzick. "Reimbursement Incentives for Hospital Care". Annual Review of Public Health 7, n.º 1 (mayo de 1986): 391–409. http://dx.doi.org/10.1146/annurev.pu.07.050186.002135.
Texto completoHui, Clayton, Haroon Kisana, John R. Martin, Chad Stecher y Joshua Hustedt. "Trends in Medicare Physician and Facility Fee Reimbursement in Orthopaedic Foot and Ankle". Foot & Ankle Orthopaedics 7, n.º 1 (enero de 2022): 2473011421S0025. http://dx.doi.org/10.1177/2473011421s00254.
Texto completoCurtiss, Frederic R. y Beverly L. Black. "Reimbursement considerations about hospital outpatient dispensing". American Journal of Health-System Pharmacy 42, n.º 5 (1 de mayo de 1985): 1046–48. http://dx.doi.org/10.1093/ajhp/42.5.1046a.
Texto completoWang, Chan y You-hua Chen. "Reimbursement and hospital competition in China". Economic Research-Ekonomska Istraživanja 30, n.º 1 (enero de 2017): 1209–23. http://dx.doi.org/10.1080/1331677x.2017.1340177.
Texto completoMcClellan, Mark. "Hospital Reimbursement Incentives: An Empirical Analysis". Journal of Economics & Management Strategy 6, n.º 1 (1 de marzo de 1997): 91–128. http://dx.doi.org/10.1162/105864097567048.
Texto completoMcClellan, Mark. "Hospital Reimbursement Incentives: An Empirical Analysis". Journal of Economics Management Strategy 6, n.º 1 (marzo de 1997): 91–128. http://dx.doi.org/10.1111/j.1430-9134.1997.00091.x.
Texto completoLinton, O. W. "Medicare amendments change teaching hospital reimbursement." Radiology 161, n.º 2 (noviembre de 1986): 567–68. http://dx.doi.org/10.1148/radiology.161.2.3532198.
Texto completoPalley, Michael A. "Hospital information systems and DRG reimbursement". Information & Management 20, n.º 3 (marzo de 1991): 227–34. http://dx.doi.org/10.1016/0378-7206(91)90057-9.
Texto completoHarris, Burton H., Kathryn Dirkes Bass y Mary D. O'Brien. "Hospital reimbursement for pediatric trauma care". Journal of Pediatric Surgery 31, n.º 1 (enero de 1996): 78–81. http://dx.doi.org/10.1016/s0022-3468(96)90323-1.
Texto completoSeldon, James R. "Hospital cost-shifting under fractional reimbursement". Atlantic Economic Journal 14, n.º 1 (marzo de 1986): 50–58. http://dx.doi.org/10.1007/bf02303510.
Texto completoStoffel, Victoria, Justin M. Camacho, Connor Heeb, Saishi Cui, Jalene Y. Shim, Salvatore J. Pacella, Amanda A. Gosman y Chris M. Reid. "Unveiling the Hidden Discrepancies Between Medicare Physician Reimbursement Rates and Inflation Across Different Surgical Specialties". Annals of Plastic Surgery 92, n.º 5S (mayo de 2024): S340—S344. http://dx.doi.org/10.1097/sap.0000000000003806.
Texto completoWolf, Sarah, Ingrid Zechmeister-Koss, Nicole Grössmann y Claudia Wild. "Evaluating options for decision making on costly hospital drugs in Austria". International Journal of Technology Assessment in Health Care 36, n.º 3 (14 de mayo de 2020): 277–84. http://dx.doi.org/10.1017/s0266462320000276.
Texto completoSinzobahamvya, Nicodème, Thorsten Kopp, Claudia Arenz, Hedwig C. Blaschczok, Viktor Hraska y Boulos Asfour. "Reimbursement by current German Diagnosis-Related Groups system penalises complex congenital heart surgery". Cardiology in the Young 24, n.º 2 (13 de mayo de 2013): 344–50. http://dx.doi.org/10.1017/s1047951113000437.
Texto completoMerritt-Myrick, Samirah y David Harris III. "Successful Billing Strategies in the Hospital Industry". International Journal of Human Resource Studies 11, n.º 1 (15 de enero de 2020): 85. http://dx.doi.org/10.5296/ijhrs.v11i1.18212.
Texto completoDonovan, Melissa J., Daniel E. Ramirez, Gregory D. Crenshaw, Taylor A. Smith, Hernan A. Bazan y W. Charles Sternbergh. "Hospital Reimbursement for Carotid Stenting and Endarterectomy". Journal of Endovascular Therapy 21, n.º 2 (abril de 2014): 296–302. http://dx.doi.org/10.1583/13-4549.1.
Texto completoDegrassat-Théas, A., M. Bensadon, C. Rieu, M. Angalakuditi, C. Le Pen y P. Paubel. "Hospital Reimbursement Price Cap for Cancer Drugs". PharmacoEconomics 30, n.º 7 (julio de 2012): 565–73. http://dx.doi.org/10.2165/11588320-000000000-00000.
Texto completoSederer, Lloyd I., Susan V. Eisen, Diana Dill, Mollie C. Grob, Michele L. Gougeon y Steven M. Mirin. "Case-Based Reimbursement for Psychiatric Hospital Care". Psychiatric Services 43, n.º 11 (noviembre de 1992): 1120–26. http://dx.doi.org/10.1176/ps.43.11.1120.
Texto completoBowers, Mary Lou. "A Reimbursement Primer for Hospital Oncology Programs". Oncology Issues 19, n.º 3 (mayo de 2004): 41–44. http://dx.doi.org/10.1080/10463356.2004.11883195.
Texto completoPope, Gregory C. "Hospital nonprice competition and medicare reimbursement policy". Journal of Health Economics 8, n.º 2 (junio de 1989): 147–72. http://dx.doi.org/10.1016/0167-6296(89)90001-5.
Texto completoRodrigues, Jose. "Hospital utilization and reimbursement method in Brazil". International Journal of Health Planning and Management 4, n.º 1 (enero de 1989): 3–15. http://dx.doi.org/10.1002/hpm.4740040103.
Texto completoMilcent, Carine. "Hospital ownership, reimbursement systems and mortality rates". Health Economics 14, n.º 11 (2005): 1151–68. http://dx.doi.org/10.1002/hec.1010.
Texto completoWolf, Sarah y Claudia Wild. "PP87 Inpatient Drug Reimbursement: Approaches For A Democratic Process". International Journal of Technology Assessment in Health Care 35, S1 (2019): 54–55. http://dx.doi.org/10.1017/s0266462319002289.
Texto completoSmith, Brian S., Walter S. Schroeder y Gary R. Tataronis. "Hospital Reimbursement for Adult Patients with Severe Sepsis Treated with Drotrecogin Alfa (Activated)". Hospital Pharmacy 40, n.º 2 (febrero de 2005): 146–53. http://dx.doi.org/10.1177/001857870504000206.
Texto completoGoetz, Gregor, Dimitra Panteli, Reinhard Busse y Claudia Wild. "PP112 Reimbursement Decisions for Medical Services in Austria: An Analysis of Influencing Factors for the Hospital Individual Services Catalogue". International Journal of Technology Assessment in Health Care 38, S1 (diciembre de 2022): S77. http://dx.doi.org/10.1017/s0266462322002355.
Texto completo